Table 1.
Baseline characteristics between control and PCOS women.
| Variables | Control baseline | PCOS baseline | P-value |
|---|---|---|---|
| (n = 10) | (n = 11) | ||
| Age (years) | 24.26 ± 6.18 | 28.00 ± 6.72 | 0.202 |
| Body mass (kg) | 71.04 ± 16.42 | 85.45 ± 18.91 | 0.080 |
| SBP (mmHg) | 123.00 ± 11.44 | 132.36 ± 11.47 | 0.027a |
| DBP (mmHg) | 77.50 ± 9.30 | 81.82 ± 11.21 | 0.290 |
| VO2max (ml.min−1.kg−1) | 36.26 ± 6.38 | 26.32 ± 4.63 | <0.001a |
| BMI (kg.m2) | 25.92 ± 5.39 | 31.15 ± 6.30 | 0.056 |
| WHR | 0.79 ± 0.07 | 0.86 ± 0.06 | 0.019a |
| WC (cm) | 83.01 ± 14.20 | 98.05 ± 16.35 | 0.033 |
| Glucose disposal (mg/kg min−1) | 4.80 ± 1.73 | 3.26 ± 0.80 | 0.016 |
| CD105 + MP (per μl PFP) | 388.2 ± 113.5 | 2,113.9 ± 951.7 | 0.021a |
| CD106 + MP (per μl PFP) | 7,165.1 ± 4403.8 | 7,625.6 ± 5,427.8 | 0.942 |
Body mass, SBP, DBP, VO2max, BMI, WHR, WC, CD105+ MP and CD106+ MP are compared at baseline between the two groups.
a
Significantly different between groups (p < 0.05). All data represented as mean ± SD, except for CD105+ MP and CD106+ MP which are represented as mean ± SEM.